These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38255857)

  • 21. Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia.
    Calleja JL; Albillos A; Moreno-Otero R; Rossi I; Cacho G; Domper F; Yebra M; Escartín P
    Aliment Pharmacol Ther; 1999 Sep; 13(9):1179-86. PubMed ID: 10468699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection.
    Agnello V
    Springer Semin Immunopathol; 1997; 19(1):111-29. PubMed ID: 9266635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of mixed cryoglobulinemia despite cure of hepatitis C with new oral antiviral therapy including direct-acting antiviral sofosbuvir: A case series.
    Cornella SL; Stine JG; Kelly V; Caldwell SH; Shah NL
    Postgrad Med; 2015 May; 127(4):413-7. PubMed ID: 25746436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal CD4 + T helper (Th) 1 cells and activated memory B cells are associated with type III asymptomatic mixed cryoglobulinemia in HCV infection.
    Kong F; Zhang W; Feng B; Zhang H; Rao H; Wang J; Cong X; Wei L
    Virol J; 2015 Jul; 12():100. PubMed ID: 26129991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatment.
    Boglione L; Cusato J; Allegra S; Cariti G; Di Perri G; D'Avolio A
    Arch Virol; 2015 Aug; 160(8):2009-17. PubMed ID: 26060059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic Association of Hepatitis C-Related Mixed Cryoglobulinemia: A 10-Year Prospective Study of Asians Treated with Antivirals.
    Chang ML; Chang SW; Chen SC; Chien RN; Hsu CL; Chang MY; Fann CSJ
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33799903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term effects of the new direct antiviral agents (DAAs) therapy for HCV-related mixed cryoglobulinaemia without renal involvement: a multicentre open-label study.
    Mazzaro C; Dal Maso L; Quartuccio L; Ghersetti M; Lenzi M; Mauro E; Bond M; Casarin P; Gattei V; Crosato IM; De Vita S; Pozzato G
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):107-114. PubMed ID: 29465371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term remission with rituximab in a patient with severe hepatitis C virus-induced mixed cryoglobulinemia.
    Fortea-Ormaechea JI; Lozano-Maya M; Adán-Merino L; Barrio-Antoranz J; Martín-Chavarri S; Corchete-Prats E; Martínez-Acebes E; Aldeguer-Martínez M
    Rev Esp Enferm Dig; 2013 Sep; 105(8):490-3. PubMed ID: 24274448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed Cryoglobulinemia.
    Emery JS; Kuczynski M; La D; Almarzooqi S; Kowgier M; Shah H; Wong D; Janssen HLA; Feld JJ
    Am J Gastroenterol; 2017 Aug; 112(8):1298-1308. PubMed ID: 28291241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy.
    Mazzaro C; Quartuccio L; Adinolfi LE; Roccatello D; Pozzato G; Nevola R; Tonizzo M; Gitto S; Andreone P; Gattei V
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus-associated mixed cryoglobulinemia. Clinical manifestations, histopathological changes, mechanisms of cryoprecipitation and options of treatment.
    Schott P; Hartmann H; Ramadori G
    Histol Histopathol; 2001 Oct; 16(4):1275-85. PubMed ID: 11642746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus.
    Saadoun D; Aaron L; Resche-Rigon M; Pialoux G; Piette JC; Cacoub P;
    AIDS; 2006 Apr; 20(6):871-7. PubMed ID: 16549971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefit of direct-acting antiviral therapy for hepatitis C virus (HCV) in monoinfected and HIV-HCV-coinfected patients with mixed cryoglobulinaemia.
    Miailhes P; Hartig-Lavie K; Virlogeux V; Pradat P; Diakite M; Uhres AC; Zoulim F; Sarda MN
    Clin Microbiol Infect; 2018 Nov; 24(11):1215.e1-1215.e4. PubMed ID: 29870852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current therapeutic strategies for HCV-associated cryoglobulinemia].
    Iannuzzella F; Garini G
    Reumatismo; 2008; 60(3):163-73. PubMed ID: 18854876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Causes and predictive factors of mortality in a cohort of patients with hepatitis C virus-related cryoglobulinemic vasculitis treated with antiviral therapy.
    Landau DA; Scerra S; Sene D; Resche-Rigon M; Saadoun D; Cacoub P
    J Rheumatol; 2010 Mar; 37(3):615-21. PubMed ID: 20110523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of BAFF -871C/T Promoter Polymorphism with Hepatitis C-Related Mixed Cryoglobulinemia in a Cohort of Egyptian Patients.
    Ayad MW; Elbanna AA; Elneily DA; Sakr AS
    Mol Diagn Ther; 2015 Apr; 19(2):99-106. PubMed ID: 25800158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab.
    Petrarca A; Rigacci L; Monti M; Giannini C; Bernardi F; Caini P; Colagrande S; Bosi A; Laffi G; Zignego AL
    Dig Liver Dis; 2007 Sep; 39 Suppl 1():S129-33. PubMed ID: 17936214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virus.
    Sene D; Ghillani-Dalbin P; Thibault V; Guis L; Musset L; Duhaut P; Poynard T; Piette JC; Cacoub P
    J Rheumatol; 2004 Nov; 31(11):2199-206. PubMed ID: 15517633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia.
    Antonelli A; Ferri C; Ferrari SM; Ghiri E; Marchi S; Colaci M; Bruschi F; Fallahi P
    Clin Rheumatol; 2009 Oct; 28(10):1179-85. PubMed ID: 19543846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study.
    Dammacco F; Tucci FA; Lauletta G; Gatti P; De Re V; Conteduca V; Sansonno S; Russi S; Mariggiò MA; Chironna M; Sansonno D
    Blood; 2010 Jul; 116(3):343-53. PubMed ID: 20308602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.